Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
protein homeostatis
Biotech
Ranok raises $40M to become the protein degrader CHAMP
Ranok claims its protein degradation technology improves on PROTAC because selective accumulation in tumors results in a wider safety margin.
Nick Paul Taylor
Aug 18, 2021 8:25am
British biotech Mission dubs Pfizer lead investor
Jul 6, 2020 7:35am
Ubiquigent DUB inhibitor pact survives Bristol-Celgene merger
Jun 18, 2020 8:40am
Celgene backs Cleave in $37M financing to tame protein homeostasis
Aug 8, 2016 7:30am
